BeStock  
Stocks › Biotechnology › ANRO

Alto Neuroscience ANRO

US equityMarket cap rank #3294Biotechnology
$23.52 −$0.17 (-0.72%)
Pre-market · Oct 8, 8:20 am ET · After hours $23.97 +1.92%
Open$23.39
Prev close$23.69
Day range$23.33 – $24.42
Volume348.0K
Market cap$922.97M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$29.13M-55.9% YoY
Net profit-$27.64M-56.1% YoY
Diluted EPS-$0.65+0.0% YoY
Free cash flow-$19.76M-43.4% YoY
Operating cash flow-$19.76M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-16.8MSep '24$-15.2MDec '24$-15.2MMar '25$-17.7MJun '25$-14.2MSep '25$-16.2MDec '25$-26.2MMar '26$-27.6MJun '26

Diluted EPS by quarter

-0.62Sep '24-0.56Dec '24-0.56Mar '25-0.65Jun '25-0.52Sep '25-0.45Dec '25-0.80Mar '26-0.65Jun '26

Free cash flow by quarter

$-12.7MSep '24$-13.5MDec '24$-16.6MMar '25$-13.8MJun '25$-9.9MSep '25$-11.5MDec '25$-27.6MMar '26$-19.8MJun '26

Annual revenue

$210.0KFY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-49.2%
Return on assets-40.9%
Return on invested capital-45.1%
Current ratio14.85
Liabilities / assets13.7%
Cash & investments$243.73M
Total debt$21.93M
Net cash (debt)$221.80M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $0.00 $0.00 – – $0.00
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $29.13M $27.14M $66.36M $17.06M $14.95M
Selling and Admin Expenses $7.02M $6.84M $20.75M $5.06M $4.43M
-General & Admin Expense $7.02M $6.84M $20.75M $5.06M $4.43M
Research & Development $22.11M $20.29M $45.62M $12.00M $10.53M
Operating Profit -$29.13M -$27.14M -$66.36M -$17.06M -$14.95M
Net Non-Operating Interest Income (Expense) $1.62M $1.02M $4.13M $986,000.00 $882,000.00
Non-Operating Interest Income $2.11M $1.56M $6.60M $1.56M $1.53M
Non-Operating Interest Expense $491,000.00 $545,000.00 $2.47M $575,000.00 $650,000.00
Other Income (Expense) -$130,000.00 -$115,000.00 -$1.01M -$113,000.00 -$112,000.00
Special Income (Charges) $0.00 $0.00 -$681,000.00 $0.00 $0.00
Other Non-Operating Income (Expenses) -$130,000.00 -$115,000.00 -$327,000.00 -$113,000.00 -$112,000.00
Pretax Profit -$27.64M -$26.24M -$63.24M -$16.18M -$14.18M
Net Profit -$27.64M -$26.24M -$63.24M -$16.18M -$14.18M
Profit from Continuing Operations -$27.64M -$26.24M -$63.24M -$16.18M -$14.18M
Net Income to Parent Company -$27.64M -$26.24M -$63.24M -$16.18M -$14.18M
Net Income to Common Stockholders -$27.64M -$26.24M -$63.24M -$16.18M -$14.18M
Basic EPS -$0.65 -$0.80 -$2.19 -$0.45 -$0.52
Diluted EPS -$0.65 -$0.80 -$2.19 -$0.45 -$0.52
-Less:Other Special Charges – – $681,000.00 $0.00 –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $254.07M $276.26M $184.69M $184.69M $147.01M
Total Current Assets $247.32M $269.13M $177.72M $177.72M $139.45M
Cash and Cash Equivalents & Short-Term Investments $243.73M $263.76M $176.48M $176.48M $137.82M
-Cash and Cash Equivalents $243.73M $263.76M $176.48M $176.48M $137.82M
Prepaid Assets $3.59M $5.36M $1.23M $1.23M $1.63M
Total Non-Current Assets $6.75M $7.13M $6.97M $6.97M $7.56M
Net PPE $5.91M $6.30M $6.13M $6.13M $6.49M
-Gross PPE $7.80M $8.00M $7.66M $7.66M $7.86M
-Accumulated Depreciation -$1.89M -$1.71M -$1.53M -$1.53M -$1.37M
Other Non-Current Assets $838,000.00 $838,000.00 $838,000.00 $838,000.00 $1.07M
Total Liabilities $34.82M $32.89M $33.55M $33.55M $35.45M
Total Current Liabilities $16.65M $13.12M $11.33M $11.33M $9.05M
Payables $4.02M $3.37M $1.88M $1.88M $2.06M
-Accounts Payable $4.02M $3.37M $1.88M $1.88M $2.06M
Current Accrued Expenses $7.50M $6.31M $7.71M $7.71M $5.87M
Short-Term Debt and Capital Lease Obligation $5.13M $3.44M $1.74M $1.74M $1.12M
-Current Debt $3.77M $2.14M $585,000.00 $585,000.00 –
-Current Capital Lease Obligation $1.36M $1.30M $1.15M $1.15M $1.12M
Total Non-Current Liabilities $18.17M $19.78M $22.22M $22.22M $26.40M
Long Term Debt and Capital Lease Obligation $18.17M $19.78M $22.22M $22.22M $26.40M
-Long Term Debt $14.88M $16.22M $18.40M $18.40M $22.44M
-Long Term Capital Lease Obligation $3.28M $3.56M $3.82M $3.82M $3.97M
Total Equity $219.25M $243.37M $151.14M $151.14M $111.56M
Stockholders' Equity $219.25M $243.37M $151.14M $151.14M $111.56M
Capital Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
-Common Stock $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00
Additional Paid-In Capital $474.74M $471.22M $352.75M $352.75M $296.99M
Retained Earnings -$255.51M -$227.87M -$201.63M -$201.63M -$185.45M
Gains/Losses Not Affecting Retained Earnings $17,000.00 $13,000.00 $22,000.00 $22,000.00 $14,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$19.76M -$27.09M -$51.77M -$11.52M -$9.92M
Net cash flow from continuing operations -$19.76M -$27.09M -$51.77M -$11.52M -$9.92M
Net Income from Continuing Operations -$27.64M -$26.24M -$63.24M -$16.18M -$14.18M
Gain/Loss from Continuing Operations $0.00 $9,000.00 $837,000.00 $0.00 $114,000.00
Depreciation & Depletion & Amortization $184,000.00 $184,000.00 $661,000.00 $157,000.00 $164,000.00
Other Non-Cash Items $498,000.00 $522,000.00 $1.83M $463,000.00 $499,000.00
Change in Working Capital $3.64M -$4.39M $33,000.00 $2.10M $1.30M
-Change in Prepaid Assets $1.78M -$4.13M $101,000.00 $656,000.00 $628,000.00
-Change in Payables and Accrued Expense $1.86M -$263,000.00 -$68,000.00 $1.44M $669,000.00
Net cash flow from investing $0.00 -$556,000.00 -$24,000.00 $0.00 $0.00
Net Cash Flow from Continuing Investing Activities $0.00 -$556,000.00 -$24,000.00 $0.00 $0.00
Capital Expenditure $0.00 -$556,000.00 -$24,000.00 $0.00 $0.00
Financing Cash Flow -$273,000.00 $114.94M $60.08M $50.19M $153,000.00
Net Cash Flow from Continuing Financing Activities -$273,000.00 $114.94M $60.08M $50.19M $153,000.00
Net Issuance Payments Of Debt $0.00 $0.00 $9.48M $0.00 $0.00
Net Common Stock Issuance -$348,000.00 $115.13M $49.83M $49.83M $0.00
Proceeds from Stock Option Exercised $75,000.00 $6,000.00 $703,000.00 $352,000.00 $153,000.00
Ending Cash Balance $244.23M $264.26M $176.98M $176.98M $138.32M
Net Change in Cash -$20.03M $87.29M $8.29M $38.67M -$9.77M
Beginning Cash Balance $264.26M $176.98M $168.73M $138.32M $148.09M
Effect of Exchange Rate Changes $4,000.00 -$16,000.00 -$30,000.00 -$1,000.00 -$4,000.00
Free Cash Flow -$19.76M -$27.65M -$51.79M -$11.52M -$9.92M
Net Other Financing Charges – -$190,000.00 $67,000.00 $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on ANRO.

Leave a comment

Scroll to Top